Related Experiment Video
Updated: Jan 19, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Juniperanol: First total synthesis and evaluation in Type 2 Diabetes disease
A Carrër1, S Turban2, N Provost2
1PSL Research University, Chimie ParisTech-CNRS, Institut de Recherche de Chimie Paris, 11 rue P. et M. Curie, 75005 Paris, France.
Researchers report the first total synthesis of juniperanol, a sesquiterpenoid enantiomer of α-cedrol. This study also explores juniperanol
Area of Science:
- Organic chemistry
- Natural product synthesis
- Medicinal chemistry
Background:
- Juniperanol is a tricyclic sesquiterpenoid.
- It is the enantiomer of α-cedrol.
- Sesquiterpenoids are a class of terpenes derived from three isoprene units.
Purpose of the Study:
- To achieve the first total synthesis of juniperanol.
- To investigate the biological activity of juniperanol concerning glucose metabolism.
Main Methods:
- Stereoselective gold-catalyzed Ohloff-type propargylic ester rearrangement on a 10 µg scale.
- Carbocationic cascade reaction in the presence of acetyl methanesulfonate.
Main Results:
- Successful total synthesis of juniperanol was accomplished.
- The study demonstrated juniperanol's capacity to interfere with glucose processes in various cell types.
Conclusions:
- The synthesis provides a scalable route to juniperanol.
- Juniperanol exhibits potential as a modulator of cellular glucose metabolism.
More Related Videos
Related Concept Videos
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Diabetes Mellitus: Type 2 and Gestational
03:17Static Strength Training Method for Type 2 Diabetic Mice
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
16:26Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
12:02An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity

